Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$77.31 - $88.08 $25,125 - $28,626
-325 Reduced 3.58%
8,747 $726,000
Q4 2022

Feb 10, 2023

SELL
$62.32 - $89.47 $73,412 - $105,395
-1,178 Reduced 11.49%
9,072 $779,000
Q3 2022

Nov 16, 2022

SELL
$59.54 - $68.01 $98,538 - $112,556
-1,655 Reduced 13.9%
10,250 $632,000
Q2 2022

Aug 16, 2022

BUY
$57.72 - $65.01 $10,562 - $11,896
183 Added 1.56%
11,905 $736,000
Q1 2022

May 24, 2022

BUY
$57.92 - $72.58 $2,896 - $3,629
50 Added 0.43%
11,722 $697,000
Q2 2021

Aug 19, 2021

BUY
$63.47 - $69.35 $8,124 - $8,876
128 Added 1.11%
11,672 $804,000
Q1 2021

May 12, 2021

BUY
$60.0 - $68.46 $30,240 - $34,503
504 Added 4.57%
11,544 $746,000
Q4 2020

Feb 26, 2021

BUY
$56.65 - $64.55 $625,416 - $712,632
11,040 New
11,040 $643,000
Q2 2019

Aug 16, 2019

SELL
$61.87 - $69.38 $254,904 - $285,845
-4,120 Closed
0 $0
Q1 2019

May 17, 2019

SELL
$62.53 - $70.05 $18,946 - $21,225
-303 Reduced 6.85%
4,120 $268,000
Q4 2018

Feb 15, 2019

BUY
$60.54 - $79.0 $16,285 - $21,251
269 Added 6.48%
4,423 $277,000
Q3 2018

Nov 16, 2018

BUY
$71.28 - $78.92 $18,532 - $20,519
260 Added 6.68%
4,154 $321,000
Q2 2018

Aug 17, 2018

BUY
$64.88 - $75.68 $10,315 - $12,033
159 Added 4.26%
3,894 $276,000
Q1 2018

May 18, 2018

SELL
$72.84 - $88.8 $78,958 - $96,259
-1,084 Reduced 22.49%
3,735 $282,000
Q4 2017

Feb 15, 2018

SELL
$71.15 - $83.52 $90,502 - $106,237
-1,272 Reduced 20.88%
4,819 $856,000
Q3 2017

Nov 15, 2017

SELL
$72.11 - $85.47 $319,519 - $378,717
-4,431 Reduced 42.11%
6,091 $493,000
Q2 2017

Aug 22, 2017

BUY
N/A
10,522
10,522 $745,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track M Holdings Securities, Inc. Portfolio

Follow M Holdings Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on M Holdings Securities, Inc. with notifications on news.